2-amino-1,2-diphenylethanol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 22243 |
| CHEMBL ID | 2152533 |
| SCHEMBL ID | 186279 |
| MeSH ID | M0523800 |
| Synonym |
|---|
| alpha-hydroxy-beta-aminodibenzyl |
| nsc 10778 |
| ethanol, 2-amino-1,2-diphenyl-, l-(+)- |
| beta-amino-alpha-phenylbenzeneethanol |
| 2-hydroxy-1,2-diphenylethylamine |
| beta-amino-alpha-hydroxybibenzyl |
| 1,2-diphenyl-2-hydroxyethylamine |
| sym-diphenylethanolamine |
| 1-hydroxy-2-aminodiphenylethane |
| 530-36-9 |
| benzeneethanol, .beta.-amino-.alpha.-phenyl- |
| nsc-10778 |
| wln: zyr&yqr |
| nsc10778 |
| 2-amino-1,2-diphenylethanol |
| (sym-diphenylethanol)amine |
| ethanol,2-diphenyl-, l-(+)- |
| iso-2-amino-1,2-diphenylethanol |
| 2-amino-1,2-diphenyl-ethanol |
| nsc409502 |
| nsc-409505 |
| nsc409505 |
| nsc-409502 |
| 3764-63-4 |
| AKOS000163721 |
| FT-0660468 |
| CHEMBL2152533 |
| benzeneethanol, beta-amino-alpha-phenyl- |
| ethanol, 2-amino-1,2-diphenyl- |
| FT-0601281 |
| FT-0604541 |
| (r,r)-(+)-2-amino-1,2-diphenylethanol |
| 23412-95-5 |
| SCHEMBL186279 |
| SY004770 |
| SY006467 |
| 2-amino-1,2-diphenylethanol # |
| AKOS025116607 |
| CS-0201433 |
| FT-0774173 |
| FT-0772439 |
| SB12118 |
| benzeneethanol, beta-amino-alpha-phenyl-, (alphar,betas)-rel- |
| noname_3883 |
| DTXSID70903251 |
| SB40874 |
| SB40861 |
| 2-amino-1,2-diphenylethan-1-ol |
| EN300-37511 |
| dl-erythro-2-amino-1,2-diphenylethanol |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID692804 | Inhibition of human Kv1.5 ion channel after 3 mins by high-throughput planar patch clamp assay | 2012 | ACS medicinal chemistry letters, Sep-13, Volume: 3, Issue:9 | Symmetric kv1.5 blockers discovered by focused screening. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.46) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||